GeneDx Holdings Corp. (WGS)

40.55 +5.84 (+16.83%) USD  |  NASDAQ  |  May 07, 16:00
39.81 -0.74 (-1.82%) After-Hours: 19:18
More

GeneDx Holdings Research and Development Expense (Quarterly) : 19.58M for March 31, 2026

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for WGS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Illumina, Inc. 240.00M
Natera, Inc. 175.19M
Guardant Health, Inc. 98.26M
Delcath Systems, Inc. 9.371M
CytoSorbents Corp. 1.243M